Achillion Pharmaceuticals
Next generation antivirals

Acurian
Clinical trials recruitment

Aerovance
Novel therapeutics for the manegement of asthma

Agile Therapeutics
Women's health pharmaceuticals

Aires Pharmaceuticals
Pulmonary-focused drug development

Clarus Therapeutics
Next generation testosterone therapy

Eagle Pharmaceutical
Specialty pharmaceuticals

Excaliard Pharmaceuticals
Novel skin therapeutics

Immune Design Corporation
Develops next generation adjuvants

Keryx Biopharmaceuticals
Cancer and renal therapeutics

Mersana Therapeutics
Novel polymer-based therapeutics

MethylGene
Small molecule enzyme inhibitors

NovaDel Pharma
Novel delivery of pharmaceuticals

Orthocon
Orthopedics medical devices

Palkion
Novel therapeutics to treat anemia

Pharmacyclics
First in class cancer therapy

Predictive
Anatomic pathology laboratory & proprietary diagnostic development

ReVision
Implantable medical devices to improve vision

Rigel Pharmaceuticals
Anti-inflammatory therapeutics

SomaLogic
Aptamer-based microarrays

Sopherion
Cancer therapeutics

TeLoRmedix
Cancer therapeutics

Tragara Pharmaceuticals
Cancer and anti-inflammatory therapeutics

Zosano Pharma
Novel microneedle transdermal patch technology

ACMI
Endoscopy systems. Acquired by Gyrus Corporation, now Olympus.

ActivX Biosciences
Molecularly targeted therapeutics. Acquired by Kyorin.

Affymax
Supportive care for life-threatening conditions

Artemis Medical
Minimally-invasive tumor biopsy. Acquired by Johnson & Johnson.

Avanir Pharmaceuticals
Novel CNS drugs

Axys Pharmaceuticals
Technology-driven drug discovery

BioRexis
Protein engineering for improved biologics. Acquired by Pfizer.

Biosyntech
Advanced biotherapeutic thermogels

Cabrellis Pharmaceuticals
Small molecule cancer therapeutics. Acquired by Pharmion, now Celgene Corp.

Cadence Pharmaceuticals
Hospital specialty pharmaceuticals

Cell Therapeutics
Cancer therapeutics

Concentric Medical
Minimally invasive devices. Acquired by Stryker Corporation.

Conforma Therapeutics
Small molecule cancer therapeutics. Acquired by Biogen Idec.

Cypress Bioscience
Pain and CNS therapeutics

Cytogen
Specialty products for oncology and pain

Eos Biotechnology
Therapeutic antibodies. Acquired by PDL Biopharma.

Epic Therapeutics
Microsphere-based drug delivery. Acquired by Baxter.

Gemin X Biotechnologies
Small molecule cancer therapeutics. Acquired by Cephalon, now Teva.

Genta
Cancer therapeutics

Gloucester Pharmaceuticals
Cancer therapeutics. Acquired by Celgene Corp.

Guava Technologies
Cell analysis platform. Acquired by Millipore.

Iomai Corporation
Transcutaneous immunization. Acquired by Intercell.

LEAD Therapeutics
Novel oncology therapeutics and anti-infectives. Acquired by BioMarin

Oncology.com
Cancer information website

Optimer Pharmaceuticals
Anti-infective therapeutics

Palatin Technologies
Novel receptor-mediated therapeutics

Pharmion
Specialty cancer pharmaceuticals. Acquired by Celgene Corp.

Point Therapeutics
Small molecule cancer therapeutics

Salmedix
Specialty oncology products. Acquired by Cephalon, now Teva.

Threshold Pharmaceuticals
Metabolic targeting in oncology

Transcept
CNS-focused specialty pharma

US Bioscience
Cancer therapeutics. Acquired by MedImmune.

Ziopharm Oncology
Small molecule cancer therapeutics